Provided by Tiger Fintech (Singapore) Pte. Ltd.

Titan Pharmaceuticals

3.70
-0.0900-2.37%
Post-market: 4.200.5000+13.51%18:32 EDT
Volume:2.57K
Turnover:9.92K
Market Cap:3.38M
PE:-0.71
High:4.11
Open:3.75
Low:3.70
Close:3.79
Loading ...

Company Profile

Company Name:
Titan Pharmaceuticals
Exchange:
NASDAQ
Establishment Date:
1991
Employees:
4
Office Location:
10 East 53rd St.,Suite 3001,New York,New York,United States
Zip Code:
10022
Fax:
- -
Introduction:
Titan Pharmaceuticals, Inc., a pharmaceutical company, develops therapeutics for the treatment of chronic diseases in the United States and internationally. It develops products based on ProNeura, a proprietary long-term drug delivery platform. It also develops TP-2021 in combination with ProNeura technology for the treatment of chronic pruritus, a severe and debilitating condition defined as itching of the skin lasting longer than six weeks; and Nalmefene implant program for the prevention of opioid relapse following detoxification of patients suffering opioid use disorder. The company was founded in 1991 and is based in South San Francisco, California.

Directors

Name
Position
David Lazar
Director,Chief Executive Officer
Marc Rubin
Executive Chairman
Katherine Beebe DeVarney
President and Chief Operating Officer,Director
Avraham Ben Tzvi
Director
David Natan
Director
Eric Greenberg
Director
James R. McNab, Jr.
Director
Joseph A. Akers
Director
M. David MacFarlane
Director
Matthew C. McMurdo
Director
Peter L. Chasey
Director

Shareholders

Name
Position
David Lazar
Director,Chief Executive Officer
Katherine Beebe DeVarney
President and Chief Operating Officer,Director